| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -12,950 | -3,438 |
| Depreciation and amortization | 9,705 | 6,488 |
| Equity-based compensation | 3,716 | 2,591 |
| Non-cash interest expense amortization of debt costs | 378 | 242 |
| Loss on impairment of long-lived assets | -7,245 | -108 |
| Taxes receivable | 402 | -1,251 |
| Prepaid expense and other current assets | 2,173 | 591 |
| Other assets | -7,650 | -4,918 |
| Accounts payable | -340 | -1,461 |
| Deferred revenue and patient deposits | -289 | -48 |
| Accrued and other liabilities | -6,913 | -4,208 |
| Net cash provided by operating activities | 5,627 | 5,852 |
| Purchases of property and equipment, net | 2,346 | 2,166 |
| Net cash used in investing activities | -2,346 | -2,166 |
| Payment on term loan | 12,883 | 11,973 |
| Payments for debt modification | 288 | 237 |
| Payments on revolving credit facility | 5,000 | - |
| Proceeds from public offerings, net | 13,768 | 14,008 |
| Dividends paid to shareholders | 0 | 0 |
| Payments on revolving credit facility | - | 5,000 |
| Payment of taxes withheld through vested equity-based compensation | 56 | 56 |
| Other financing activity | -1,652 | -474 |
| Net cash used in financing activities | -6,111 | -3,732 |
| Effect of exchange rate changes on cash and cash equivalents | - | 0 |
| Net decrease in cash and cash equivalents | -2,830 | -46 |
| Cash and cash equivalents at beginning of period | 8,235 | - |
| Cash and cash equivalents at end of period | 5,405 | - |
Airsculpt Technologies, Inc. (AIRS)
Airsculpt Technologies, Inc. (AIRS)